greeksoup/ stock research

Privia Health Group (PRVA) FY2023 results: revenue $1.7 billion, up 22.2% on the year

Privia Health Group, Inc. (PRVA) reported revenue of $1.7 billion for fiscal 2023, the year ended 31 December 2023, up 22.2% on the year before. Net income was $23 million, and diluted earnings per share $0.19. The figures are the company's own, from the 10-K it filed with the SEC on 27 February 2024.

Revenue
$1.7 billion
+22.2% on the year
FY2019FY2023
Operating margin
1.2%
-1.4% a year earlier
FY2019FY2023
Net income
$23 million
FY2019FY2023
Diluted EPS
$0.19
FY2019FY2023

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2023 · Q2 FY2023 · Q3 FY2023 · Q4 FY2023

Income statement (profit and loss)

$ millionFY2023FY2022FY2021On the yearLast 8 years
Revenue1,6581,357966+22.2%
Operating income20.6-19.1-217
Operating margin1.2%-1.4%-22.5%
Interest expensen/a0.51.1
Pre-tax income29.0-18.6-219
Income tax8.0-6.5-27.9
Effective tax rate27.5%n/an/a
Net income23.1-8.6-188
Net margin1.4%-0.6%-19.5%
Diluted EPS$0.19-$0.08-$1.83
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2023FY2022FY2021On the yearLast 8 years
Operating cash flow80.847.255.1+71.2%
Capital expenditure0.10.10.5+8.7%
Free cash flow80.747.154.5+71.3%
Free cash flow margin4.9%3.5%5.6%
Cash from investing-43.0-0.1-32.8
Cash from financing3.7-19.7214
Depreciation and amortisation6.54.62.5+42.9%
Share-based compensation37.167.4254-44.9%
Diluted shares, weighted125m111m103m+12.6%
Shares outstanding at period end118m115m108m+3.1%

Balance sheet

$ millionFY2023FY2022FY2021On the yearLast 8 years
Shareholders' equity561499427+12.5%
Non-controlling interest46.020.023.3+130.3%
Debt0.00.031.7
Operating lease liabilities5.28.511.0-38.2%
Other liabilities387265193+46.0%
Total liabilities and equity1,000793686+26.1%
Fixed assets2.33.44.5-31.3%
Goodwill139127128+9.3%
Intangible assets10857.459.7+87.6%
Cash and equivalents390348321+11.9%
Receivables291190117+53.4%
Other assets70.967.556.2+5.1%
Total assets1,000793686+26.1%

10-K for the year ended 31 December 2023, filed 27 February 2024: the filing.